Chapter title |
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
|
---|---|
Chapter number | 18 |
Book title |
Myelin
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7862-5_18 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7861-8, 978-1-4939-7862-5
|
Authors |
Chenyi Wang, Mark R. Kotter, Wang, Chenyi, Kotter, Mark R. |
Abstract |
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory disease in the central nervous system (CNS) characterized by loss of oligodendrocytes, myelin axons, and neurons. Remyelination is an endogenous repair mechanism, which recovers the loss of myelin and is able to preserve functional axons. The hope is that the development of new treatments aiming at promoting remyelination will halt and potentially partially reverse the progressive neurological decline in MS. The development of such drugs requires adequate models. In this chapter, we will discuss the surgical procedure of injection of lysolecithin into ventral thoraco-lumbar spinal cord white matter of mice, which is particularly suitable for investigating remyelination using transgenic animals. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 37 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 13 | 35% |
Student > Master | 4 | 11% |
Student > Bachelor | 3 | 8% |
Other | 2 | 5% |
Researcher | 2 | 5% |
Other | 5 | 14% |
Unknown | 8 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 11 | 30% |
Biochemistry, Genetics and Molecular Biology | 6 | 16% |
Medicine and Dentistry | 3 | 8% |
Agricultural and Biological Sciences | 2 | 5% |
Immunology and Microbiology | 2 | 5% |
Other | 4 | 11% |
Unknown | 9 | 24% |